Revenue for the quarter was $64,000 with operating income of $3.51 million.
The Sancarlos, California (CA)-based company operating in the biological products, except diagnostic substances sector has total shareholders equity of $1.90 million.
Also read:
This is a developing story. Click
here to receive updates.
------------
NewsInMinutes, an offering of 10kInfo, Inc., brings you news on the latest regulatory filings. Subscribe to additional news alerts
here.